Inhibrx Biosciences Inc. (INBX)
13.50
0.25 (1.89%)
At close: Mar 03, 2025, 3:59 PM
13.58
0.59%
After-hours: Mar 03, 2025, 04:00 PM EST
Inhibrx Biosciences Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 277.92M | 273.87M | 131.3M | 128.66M | 11.54M | 2.1M | 13.47M | 20.02M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 3.16M | 3.16M | 1.85M | 245K | 245K | 1.73M | n/a | -1 |
| Receivables | 778K | 257K | 878K | 615K | 438K | 690K | 696K | n/a |
| Inventory | n/a | -257K | -878K | -129.28M | 3.21M | 2.31M | 999K | n/a |
| Other Current Assets | 16.66M | 5.51M | 7.81M | 132.17M | 376K | 553K | 276K | 383K |
| Total Current Assets | 295.36M | 280.49M | 139.11M | 132.17M | 15.56M | 5.66M | 15.44M | 20.41M |
| Property-Plant & Equipment | 9.37M | 7.22M | 9.49M | 11.32M | 10.68M | 2.59M | 1.8M | 864K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 12.54M | 10.38M | 11.34M | 11.57M | 10.93M | 4.33M | 1.8M | 864K |
| Total Assets | 307.89M | 290.88M | 150.45M | 143.74M | 26.49M | 9.98M | 17.25M | 21.27M |
| Account Payables | 8.31M | 4.34M | 9.13M | 13.46M | 3.12M | 6.53M | 775K | 167K |
| Deferred Revenue | n/a | 166K | 2.03M | 3.08M | 7.94M | 1.63M | 2.61M | n/a |
| Short-Term Debt | 4.13M | 3.72M | 1.67M | 1.5M | 4.67M | 5.93M | 5.17M | 4.26M |
| Other Current Liabilities | 43.88M | 19.35M | 9.62M | 13.36M | 4.85M | 2.09M | 372K | 856K |
| Total Current Liabilities | 56.31M | 27.58M | 22.45M | 31.4M | 20.57M | 16.18M | 8.92M | 5.28M |
| Long-Term Debt | 208.08M | 205.24M | 70.47M | 35.95M | 37.06M | 3.56M | 9.49M | 14.66M |
| Other Long-Term Liabilities | n/a | n/a | 5.14M | 180K | 61.42M | 47.88M | 21.25M | 92K |
| Total Long-Term Liabilities | 208.08M | 205.24M | 75.61M | 36.87M | 99.49M | 51.45M | 30.75M | 14.75M |
| Total Liabilities | 264.39M | 232.82M | 98.07M | 68.27M | 120.06M | 67.63M | 39.67M | 20.03M |
| Total Debt | 210.14M | 202.07M | 70.47M | 37.45M | 41.73M | 9.49M | 14.66M | 18.92M |
| Common Stock | 5K | 4K | 4K | 4K | 2K | 3K | n/a | n/a |
| Retained Earnings | -613.73M | -372.37M | -227.15M | -145.38M | -69.25M | -17.86M | -28.77M | -9.25M |
| Comprehensive Income | 0.00 | n/a | -150.45M | -143.74M | -59.51M | -1.71M | -1.03M | n/a |
| Shareholders Equity | 43.5M | 58.06M | 52.38M | 75.47M | -93.57M | -57.64M | -28.77M | -9.25M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |